Created in May 2018, Zionexa is an international company developing and commercializing Molecular Imaging Companion Diagnostics (CDx) for targeted therapies in Oncology aimed to improve patients’ pathway and quality of life.
Zionexa is a spin-off of Cyclopharma, a radiopharmaceutical company producing and commercializing biomarkers in France.
MOLECUBES build preclinical imaging CUBES allowing researchers to perform high-performance SPECT/CT and PET/CT studies without complex system handling and with very limited lab space requirements. With the CUBES whole-body mice and rats are imaged while modularity accounts for the evolution of lab needs. Developed by end users its promises are simple: excellent image quality, functional design, intuitive software, high-throughput workflow and unmatched service commitments
MOLECUBES is a spin-off of Ghent University and it’s preclinical INFINITY lab. Combining more than 15 years of experience in hardware and software development, all systems are designed and built by a young team who have been end-users themselves. The engineering team is completed by a sales and management team with a long track record in the preclinical arena.
MiE medical imaging electronics
MiE medical imaging electronics
The MiE GmbH is in accordance with EN ISO 13485:2012 + AC: 2012 certified and our gamma camera systems are with Annex II of Directive 93/42/EWG approved. Also, we are registered at the FDA – our systems are 510(k) approved since 1995. This extensive certification is the basis for the manufacture and distribution of medical products on the world market.
The IRE, or Institute for Radioelements is a public utility foundation. Its main activity is the production of radioisotopes for diagnostic and treatment applications in the field of nuclear medicine. These products are the active ingredients of many radiopharmaceutical medicines.
IRE ELiT is a subsidiary of the IRE and produces several radiopharmaceutical derivatives used in the treatment of certain cancers and in palliative care.
ORA aims providing optimized radiochemical applications and to become a recognized world player in providing the best possible integrated chemistry experience meeting the regulatory and operational needs of today’s and tomorrow’s PET pharmaceutical producers and developers.
Founded in 1959, the Institute of Isotopes of the Hungarian Academy of Sciences began to produce radioactive isotopes in 1964. It became a major Hungarian centre for the research, development and production of radioisotopes. With effect from 1993 a part of the former Institute has been operating as the Institute of Isotopes Co., Ltd. (IZOTOP).
The Institute of Isotopes Co., Ltd. (Izotop) is dealing with the research, development and production of a wide variety of radioactive isotopes and other products for a broad range of application areas, especially healthcare, research and industry.
Elysia is a provider of LIMS, chromatography and quality control systems to the pharmaceutical, agrochemical and nuclear/PET industries.
We design, manufacture, sell and service instruments used in the measurement of radioactivity and quality control. We work in close collaboration with radiopharmaceutical and cyclotron providers to develop new products and improve existing solutions.
Rotem Industries Ltd, specializes in the commercialization of advanced and innovative technologies and science. Founded in early 1980’s, the company has been mandated to implement and commercialize state-of-the-art marketable innovations, reaping the technical harvest of scientific research, for the benefit of research, industrial and commercial communities worldwide.
The Radiation Detection Division is responsible for the development, manufacturing and marketing of radiation detection equipment including portable survey meters, area monitoring systems, spectroscopic portals and supporting software systems.
OAK RIDGE National Laboratory
Oak Ridge National Laboratory is the largest US Department of Energy science and energy laboratory, conducting basic and applied research to deliver transformative solutions to compelling problems in energy and security.
ORNL’s diverse capabilities span a broad range of scientific and engineering disciplines, enabling the Laboratory to explore fundamental science challenges and to carry out the research needed to accelerate the delivery of solutions to the marketplace.